RGEN
Repligen Corp
Price:  
118.15 
USD
Volume:  
615,767.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGEN Relative Valuation

-107.9%
Upside

As of 2025-05-24, the Relative Valuation of Repligen Corp (RGEN) is (9.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 118.15 USD, the upside of Repligen Corp based on Relative Valuation is -107.9%.

The range of the Relative Valuation is (8.81) - (9.35) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 25.1x - 30.6x 27.3x
Forward P/E multiples 23.7x - 26.7x 25.8x
Fair Price (8.81) - (9.35) (9.30)
Upside -107.5% - -107.9% -107.9%
118.15 USD
Stock Price
(9.30) USD
Fair Price

RGEN Relative Valuation - Historical P/E Data

Date P/E
2025-05-23 -337.21
2025-05-22 -343.78
2025-05-21 -343.09
2025-05-20 -364.15
2025-05-19 -360.16
2025-05-16 -361.04
2025-05-15 -351.80
2025-05-14 -365.44
2025-05-13 -375.46
2025-05-12 -381.65
2025-05-09 -351.74
2025-05-08 -364.90
2025-05-07 -362.13
2025-05-06 -372.17
2025-05-05 -402.20
2025-05-02 -403.88
2025-05-01 -391.58
2025-04-30 -393.84
2025-04-29 -397.95
2025-04-28 -409.93
2025-04-25 -413.13
2025-04-24 -414.50
2025-04-23 -403.57
2025-04-22 -396.52
2025-04-21 -375.71
2025-04-17 -371.03
2025-04-16 -377.03
2025-04-15 -361.39
2025-04-14 -363.21
2025-04-11 -350.65
2025-04-10 -328.76
2025-04-09 -353.48
2025-04-08 -310.78
2025-04-07 -331.39
2025-04-04 -319.49
2025-04-03 -347.34
2025-04-02 -373.66
2025-04-01 -366.75
2025-03-31 -363.16
2025-03-28 -380.76
2025-03-27 -391.35
2025-03-26 -397.95
2025-03-25 -405.14
2025-03-24 -414.27
2025-03-21 -399.63
2025-03-20 -397.69
2025-03-19 -413.50
2025-03-18 -411.96
2025-03-17 -436.13
2025-03-14 -429.88